Skip to main content

Table 3 Univariate analysis of survival

From: Survival after chemotherapy and/or radiotherapy versus self-expanding metal stent insertion in the setting of inoperable esophageal cancer: a case-control study

 

Beta

Wald

statistic

P-value*

ASA-classification

-0.034372

0.034097

0.853501

Nutrition status

-0.059647

0.310746

0.577226

Smoking

-0.282645

2.403644

0.121063

Alcohol consumption

-0.294566

2.635858

0.104485

Hepatopathy

0.066506

0.091186

0.762676

Pulmonary disease

-0.062020

0.114867

0.734672

Cardial disease

-0.276026

2.215080

0.136678

Diabetes

-0.241763

1.005458

0.316001

Secondary carcinoma

0.196181

0.924205

0.336381

Vital Capacity (VC)

-0.239513

2.552092

0.110158

FEV 1

-0.296171

3.468683

0.062550

Age

0.008591

0.774818

0.378737

Gender

0.319681

1.808111

0.178745

Procedure

0.081361

0.364907

0.545798

Histology

0.362451

4.884958

0.027099

Localization

0.241270

5.437840

0.019711

Contraindication

for surgery

-0.041959

1.555456

0.212341

Causes of incurability

-0.053454

0.340351

0.559631

Site of metastases

0.087241

1.488161

0.222511

Type of metastases

-0.346926

2.826217

0.092746

Therapy

-0.199524

7.805245

0.005213

BMI

-0.003725

0.050582

0.822056

  1. *P-values in bold depict statistical significance
  2. BMI: body mass index; ASA: American Society of Anesthesiologists classification; FEV 1 : Forced expiratory volume in 1 s